{"id":818,"date":"2020-09-01T16:32:38","date_gmt":"2020-09-01T16:32:38","guid":{"rendered":"https:\/\/www.pharmity.com\/?p=818"},"modified":"2024-11-03T15:12:19","modified_gmt":"2024-11-03T15:12:19","slug":"lack-of-assessment-of-automated-test-execution-tools","status":"publish","type":"post","link":"https:\/\/www.pharmity.com\/lack-of-assessment-of-automated-test-execution-tools\/","title":{"rendered":"Lack of Assessment of Automated Test Execution Tools"},"content":{"rendered":"\r\n\r\n\r\n
<\/p>\r\n
\r\nThe assessment and verification of a computerized test tool should focus on demonstrating that the tool is fit for purpose<\/strong> as far as critical requirements<\/h5>\r\n<\/blockquote>\r\n
The level of required verification depends on the nature of the tool and the degree of configuration and customization. Typically if a well known and accepted tool is used, a proof of its fitness for the intended purpose would be enough. This proof should focus on the critical requirements, including:<\/h5>\r\n
\r\n
- \r\n
Security of test data (e.g. role based permissions and user retriction, use of audit trails). The verification should focus on the implementation of security through the use of logical and\/or physical security controls and procedural controls.<\/h5>\r\n<\/li>\r\n
- \r\n
Enforcement of defined test processes or workflow.<\/h5>\r\n<\/li>\r\n<\/ul>\r\n
Custom or highly configured test automation tools may, based on a risk assessment, require detailed requirements definition, specifications and verification.<\/h5>\r\n
Whether you are a GxP software developer, auditor, inspector or an end user, remember\u00a0 that the test tools used for automated testing of GxP systems are required to be assessed, and that based on that assessment, a verification or testing approach will be defined to demonstrate the tool’s fit for purpose.<\/h5>\r\n
<\/p>\r\n
REFERENCES<\/span><\/strong><\/h3>\r\n
\r\n
- \r\n
International Council for Harmonization (ICH): ICH Harmonized Guideline, Integrated Addendum to ICH E6(R1): <\/span>Guideline for Good Clinical Practice<\/span> E6(R2). Step 4, version 9 November 2016. <\/span><\/span><\/h6>\r\n<\/li>\r\n
- \r\n
GAMP Good Practice Guide: A Risk-Based Approach to Testing of GxP Systems. ISPE. 2012<\/span><\/h6>\r\n<\/li>\r\n<\/ul>\r\n
<\/p>\r\n
SIGN UP for our newsletter to stay up to date on all our new articles<\/span><\/strong>
\ud83d\udc49 https:\/\/www.pharmity.com\/blog\/#newsletter<\/a><\/span><\/h4>\r\n\u00a0<\/p>\r\n
Author: Dr Leire Z\u00fa\u00f1iga, Director and Principal GCP Consultant<\/span><\/span><\/p>\r\n